Ginkgo Bioworks Hldgs Inc (DNA)
13.41 x 1 13.72 x 1
Post-market by (Cboe BZX)
13.55 +1.23 (+9.98%) 02/13/25 [NYSE]
13.41 x 1 13.72 x 1
Post-market 13.50 -0.05 (-0.37%) 19:38 ET
for Thu, Feb 13th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 251,455 | 477,706 | 313,837 | 76,657 | 54,184 |
Cost of Goods | 54,005 | 204,216 | 129,690 | 15,611 | N/A |
Gross Profit | 197,450 | 273,490 | 184,147 | 61,046 | 54,184 |
Operating Expenses | 1,061,861 | 2,482,658 | 2,013,304 | 198,684 | 125,782 |
Operating Income | -864,406 | -2,208,952 | -1,828,467 | -137,027 | -71,598 |
Interest Expense | 93 | 106 | 2,373 | 2,385 | 2,421 |
Other Income | -28,441 | 87,659 | -7,282 | 14,578 | -45,816 |
Pre-tax Income | -892,940 | -2,121,399 | -1,838,122 | -124,834 | -119,835 |
Income Tax | -71 | -15,027 | -1,480 | 1,889 | 22 |
Net Income Continuous | -892,869 | -2,106,372 | -1,836,642 | -126,723 | -119,857 |
Minority Interests | N/A | -1,443 | -6,595 | -114 | -530 |
Net Income | $-892,869 | $-2,104,929 | $-1,830,047 | $-126,609 | $-119,327 |
EPS Basic Total Ops | -18.40 | -50.00 | -54.00 | -4.00 | -4.00 |
EPS Basic Continuous Ops | -18.37 | -50.18 | -54.02 | -3.98 | -4.17 |
EPS Diluted Total Ops | -18.40 | -50.00 | -55.60 | -4.00 | -4.00 |
EPS Diluted Continuous Ops | -18.37 | -50.16 | -54.00 | -3.98 | -4.17 |
EPS Diluted Before Non-Recurring Items | -15.60 | -34.40 | -6.00 | N/A | N/A |
EBITDA(a) | $-792,852 | $-2,164,529 | $-1,799,391 | $-123,163 | $-60,843 |